Tranzyme lands drug development deal with Bristol-Myers Squibb
Get the latest news alerts: Follow LTW at Twitter. RESEARCH TRIANGLE PARK, N.C. - Tranzyme Pharma , a venture capital backed startup with proprietary drug development technology, will work with drug giant Bristol-Myers Squibb in a drug development deal potentially worth hundreds of millions of dollars.
2009-12-08 -
Local Tech Wire